UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date: February 06, 2018
Accession Number: 0001144204-18-004754
Submission Type: POS AM
CIK: 0000897075
Company Name: REPROS THERAPEUTICS INC.
File Number: 333-184159
Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Royalty Pharma Charts.
Royalty Pharma (NASDAQ:RPRX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Royalty Pharma Charts.